Mealey's PI/Product Liability - 11th Circuit Affirms Denial Of Class Certification In Pharmaceutical Tying Case

Mealey's PI/Product Liability - 11th Circuit Affirms Denial Of Class Certification In Pharmaceutical Tying Case

ATLANTA - A Florida hospital is an indirect purchaser and lacks standing to recover damages on claims that Astellas US LLC is forcing health care providers to buy its adenosine drug at a 450 percent markup compared to competitors' versions of the same drug by unlawfully tying the implied license to perform its patented cardiac test to the purchase of its unpatented drug for use during that test, the 11th Circuit U.S. Court of Appeals affirmed Aug. 15 in ruling that the hospital would not be an adequate representative for a damages class (Lakeland Regional Medical Center, Inc. v. Astellas US, LLC, et al., No. 13-12709, 11th Cir.; 2014 U.S. App. LEXIS 15669).

Access this news story on lexis.com®